Oncology One has today announced it has appointed Dr Ton Bunt as a Non-Executive Director, who brings vital expertise to the Board in the areas of product development and commercialisation.
Oncology One Chair, Mary Harney, said: “The Oncology One Board enthusiastically welcomes Dr Bunt. He has enviable credentials in the biotechnology and pharmaceutical sectors, with targeted experience in transactions and commercialisation of research and development (R&D) – all highly important areas for our Company, as we translate early-stage research into therapies that transform outcomes for people with cancer.”
